These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28322415)

  • 61. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
    Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
    BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
    DeMott JM; Patel G; Lat I
    Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Racial differences in vasopressor requirements for septic shock.
    Bauman ZM; Killu KF; Rech MA; Bernabei-Combs JL; Gassner MY; Coba VE; Tovbin A; Kunkel PL; Mlynarek ME
    Shock; 2014 Mar; 41(3):188-92. PubMed ID: 24365885
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does Switching Norepinephrine to Phenylephrine in Septic Shock Complicated by Atrial Fibrillation With Rapid Ventricular Response Improve Time to Rate Control?
    Haiduc M; Radparvar S; Aitken SL; Altshuler J
    J Intensive Care Med; 2021 Feb; 36(2):191-196. PubMed ID: 31893966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Letter to the editor: "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study".
    Bulloch MN
    J Crit Care; 2023 Apr; 74():154239. PubMed ID: 36549962
    [No Abstract]   [Full Text] [Related]  

  • 70. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock.
    Sacha GL; Kiser TH; Wright GC; Vandivier RW; Moss M; Burnham EL; Ho PM; Reynolds PM; Bauer SR
    Crit Care Med; 2022 Apr; 50(4):644-654. PubMed ID: 34605778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
    Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
    Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Association of Elevated Lactate With Multiple Vasopressor Administration in Patients With Septic Shock: A Retrospective Cohort Study.
    Gales K; Hunt M; Marler J
    J Pharm Pract; 2024 Feb; 37(1):110-117. PubMed ID: 36124978
    [No Abstract]   [Full Text] [Related]  

  • 73. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NOREPINEPHRINE: NOT TOO MUCH, TOO LONG.
    Martin C; Medam S; Antonini F; Alingrin J; Haddam M; Hammad E; Meyssignac B; Vigne C; Zieleskiewicz L; Leone M
    Shock; 2015 Oct; 44(4):305-9. PubMed ID: 26125087
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
    Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Machine learning to predict vasopressin responsiveness in patients with septic shock.
    Scheibner A; Betthauser KD; Bewley AF; Juang P; Lizza B; Micek S; Lyons PG
    Pharmacotherapy; 2022 Jun; 42(6):460-471. PubMed ID: 35426141
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tolerability of Enteral Nutrition in Mechanically Ventilated Patients With Septic Shock Who Require Vasopressors.
    Merchan C; Altshuler D; Aberle C; Papadopoulos J; Schwartz D
    J Intensive Care Med; 2017 Oct; 32(9):540-546. PubMed ID: 27377392
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients.
    Morales S; Wendel-Garcia PD; Ibarra-Estrada M; Jung C; Castro R; Retamal J; Cortínez LI; Severino N; Kiavialaitis GE; Ospina-Tascón G; Bakker J; Hernández G; Kattan E
    Crit Care; 2024 Jul; 28(1):216. PubMed ID: 38961499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.